DOI: 10.1093/braincomms/fcad235 ISSN:
Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
Michael Kyba, Darko Bosnakovski- Neurology
- Cellular and Molecular Neuroscience
- Biological Psychiatry
- Psychiatry and Mental health
This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (https://doi.org/10.1093/braincomms/fcad221)